A carregar...
The benefits of statin therapy—what questions remain?
Early hydroxymethylglutaryl‐CoA reductase inhibitor (statin) trials provided the first evidence of the benefits of statin therapy in secondary prevention of coronary heart disease (CHD). Outcomes data from more recent trials involving atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastat...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654705/ https://ncbi.nlm.nih.gov/pubmed/16450792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960281103 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|